CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,719,562
- in 13 filings, $45.5M under 10b5-1 plans
Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-20 | Gline Matthew CEO | Shares withheld for taxes | −10,945 | $11.04 | $121K | 17,283,766 |
| 2025-05-07 | Ramaswamy Vivek 10% owner | Sale | −625,000 | $11.18 | $7.0M | 39,174,611 |
| 2025-05-06 | Ramaswamy Vivek 10% owner | Sale | −273,959 | $11.47 | $3.1M | 39,799,611 |
| 2025-04-28 | Pulik Richard CFO | Shares withheld for taxes | −1,653 | $11.19 | $18K | 405,699 |
| 2025-04-21 | Pulik Richard CFO | Grant or award | +141,464 | 407,352 | ||
| 2025-04-21 | Pulik Richard CFO | Grant or award · Stock Option (Right to Buy) | +180,413 | 180,413 | ||
| 2025-04-21 | Venker Eric President & COO | Option exercise 10b5-1 | +100,000 | $3.85 | $385K | 1,216,345 |
| 2025-04-21 | Venker Eric President & COO | Sale 10b5-1 | −100,000 | $10.22 | $1.0M | 1,116,345 |
| 2025-04-21 | Venker Eric President & COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100,000 | 9,823,923 | ||
| 2025-04-20 | Venker Eric President & COO | Shares withheld for taxes 10b5-1 | −10,945 | $10.15 | $111K | 1,116,345 |
| 2025-04-20 | Gline Matthew CEO | Shares withheld for taxes | −10,945 | $10.15 | $111K | 17,294,711 |
| 2025-04-17 | Oren Ilan Director | Grant or award | +2,296 | 104,796 | ||
| 2025-04-17 | Oren Ilan Director | Shares withheld for taxes | −115 | $11.65 | $1K | 104,681 |
| 2025-04-17 | Epperly Melissa B, Director | Grant or award | +1,847 | 41,376 | ||
| 2025-04-17 | MOMTAZEE JAMES C Director | Grant or award | +1,379 | 95,986 | ||
| 2025-04-17 | MOMTAZEE JAMES C Director | Shares withheld for taxes | −276 | $10.15 | $3K | 95,710 |
| 2025-04-17 | Oren Ilan Director | Grant or award | +2,635 | 102,564 | ||
| 2025-04-17 | Oren Ilan Director | Shares withheld for taxes | −64 | $10.15 | $650 | 102,500 |
| 2025-03-28 | Pulik Richard CFO | Shares withheld for taxes | −1,653 | $10.38 | $17K | 265,888 |
| 2025-03-24 | Venker Eric President & COO | Option exercise 10b5-1 | +602,311 | $3.85 | $2.3M | 1,561,768 |
Page 23 of 29 · 570 trades